Pan-AKT Inhibitor Capivasertib With Docetaxel and Prednisolone in Metastatic Castration-Resistant Prostate Cancer: A Randomized, Placebo-Controlled Phase II Trial (ProCAID)Simon J. Crabb, Robert J. Jones, Angus Robinson et al.|Journal of Clinical Oncology|2020Cited by 82
Development and Validation of Consensus Contouring Guidelines for Adjuvant Radiation Therapy for Bladder Cancer After Radical CystectomyBrian C. Baumann, John P. Christodouleas, Walter Bosch et al.|International Journal of Radiation Oncology*Biology*Physics|2016Cited by 56
The Rationale for Post-Operative Radiation in Localized Bladder CancerBrian C. Baumann, John P. Christodouleas, Paul Sargos et al.|Bladder Cancer|2017Cited by 27
Adjuvant radiotherapy for pathological high-risk muscle invasive bladder cancer: time to reconsider?Paul Sargos, John P. Christodouleas, Brian C. Baumann et al.|Translational Andrology and Urology|2016Cited by 19
Concept: A randomised multicentre trial of first line chemotherapy comparing three weekly cabazitaxel versus weekly paclitaxel in HER2 negative metastatic breast cancerAmit Bahl, Mark Churn, William W. Wilson et al.|The Breast|2022Cited by 7